4
Changes in Ownership
NRX Pharmaceuticals, Inc. Filed Acc 0001415889-23-013137
Director bought 70,000 shares at $0.29 ($20,125)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hurvitz Chaim Director | 2023-08-30 | Purchase | +70,000 | $0.29 | $20,125 | 570,000 | D: show line 1 in the form |
| Open-market purchases · 70,000 sh · avg $0.29 · $20,125 | |||||||
Loading xslF345X05/form4-09112023_010907.xml…